
Join to view full profile
750 Washington StBoston, MA 02111
Phone+1 617-636-5000
Fax+1 617-636-8538
Dr. Buchsbaum is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
Weill Cornell MedicineClass of 1985
Harvard UniversityA.B., Chemistry & Physics, Cum Laude, 1980
Certifications & Licensure
MA State Medical License 1987 - 2027
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Exceptional Women in Medicine Castle Connolly, 2017
- Boston's Top Doctors Boston Magazine, 2017
- Zucker Clinical Teaching Prize for Innovation in Medical Education Tufts University School of Medicine, 2015
Publications & Presentations
PubMed
- N-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer.Srinidi Mohan, Douglas W Van Pelt, Jamie G Saunders, John DiPalazzo, Shelby E Monahan
Cancer Reports. 2026-07-01 - 1 citationsRisk Factors Associated with Delayed Breast Cancer Diagnoses: What Are We Missing?Katrina S Kufer, Lara K Wellis, Ashlin Harris, Meghan I Short, Anubha Bharthuar
Journal of General Internal Medicine. 2026-06-10 - Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure.Emily Anderson, Yun Choi, Rachel J Buchsbaum, Andreas Klein, Bonnie Ky
Leukemia & Lymphoma. 2025-08-01
Press Mentions
Debunking Myths About CancerJune 10th, 2022
Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: